Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Retained Earnings: 2011-2012

Historic Retained Earnings for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to -$135.3 million.

  • Sonoma Pharmaceuticals' Retained Earnings fell 3.64% to -$135.3 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$135.3 million, marking a year-over-year decrease of 3.64%. This contributed to the annual value of -$132.3 million for FY2012, which is 5.86% down from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Retained Earnings stood at -$135.3 million for Q4 2012, which was down 1.43% from -$133.4 million recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year Retained Earnings high stood at -$125.0 million for Q1 2011, and its period low was -$135.3 million during Q4 2012.
  • Over the past 2 years, Sonoma Pharmaceuticals' median Retained Earnings value was -$131.2 million (recorded in 2011), while the average stood at -$130.4 million.
  • Data for Sonoma Pharmaceuticals' Retained Earnings shows a maximum YoY declined of 5.86% (in 2012) over the last 5 years.
  • Quarterly analysis of 2 years shows Sonoma Pharmaceuticals' Retained Earnings stood at -$130.5 million in 2011, then decreased by 3.64% to -$135.3 million in 2012.
  • Its last three reported values are -$135.3 million in Q4 2012, -$133.4 million for Q3 2012, and -$131.9 million during Q2 2012.